“Chain Drug Review is extremely excited to partner with PharmaSmart®,” says Jeff Woldt, Vice President/Editorial Director of Chain Drug Review.
(PRWEB) August 19, 2015
PharmaSmart International Inc., a Rochester, N.Y.-based, “Inc. 5000” company and Chain Drug Review, the leading publication in the retail pharmacy sector, have launched a ground-breaking partnership designed to help patients cut their hypertension rates at the pharmacy point of care.
The two companies intend to generate significant awareness across community pharmacy about the chronic disease, and to jump-start efforts to reduce rates of uncontrolled blood pressure. In the process, they will reinforce the fact that retail pharmacists can and should play a major role in effective patient care. PharmaSmart® boasts a clinically powerful “out-of-office” blood pressure screening tool, while Chain Drug Review provides a unmatched conduit for communicating with members of the pharmacy profession.
PharmaSmart® biometric screening technology and Health IT Systems will serve as the driver for generating and streaming patient readings to a secure, HIPPA-compliant data center. Qualified clinicians will assess confidential data throughout the one-year duration of the program. A secure and dedicated portal that delivers de-identified results will be accessible through Chain Drug Review’s website and powered by PS DataSmart®.
The pharmacists who have the most success in helping patients lower their blood pressure will have the option to receive a contribution to their charity of choice, travel, and a Sony Play-Station and/or an Apple iPad. Prizes, which also will include multiple pizza parties throughout the year, will be awarded to individuals or groups. A dedicated portal that outlines rules for participation, program registration and specifics about the initiative is set to launch in November.
PharmaSmart® offers pharmacists and physicians a credible, accessible, low-cost solution for monitoring blood pressure that they can recommend to their patients. It offers pharmacists a unique opportunity to coordinate care with local physicians in support of improved hypertension screening, diagnosis and therapy management.
“Lowering patient blood pressure is an essential ingredient to the success of today’s health care system,” says Ashton S. Maaraba, PharmaSmart Chief Operations Officer and General Manager. “Thousands of pharmacies across U.S. and Canada utilize PharmaSmart® technology as a valuable, out-of-office resource tool to help control patient blood pressure. Teaming up with Chain Drug Review, an outstanding media partner, provides the industry with a unique channel to generate awareness, and to advance the overarching goal between both companies and community. ”
“Chain Drug Review is extremely excited to partner with PharmaSmart® on this unique collaborative effort, and in turn bring attention to the positive impact community pharmacists can have on the control of hypertension among their patients,” says Jeff Woldt, Vice President/Editorial Director of Chain Drug Review.
PharmaSmart®, headquartered in Rochester, N.Y., currently serves more than 6,500 locations, including such retail pharmacies as, Brookshire’s Grocery Company (BGC), Kinney Drugs, Bartell Drugs, Sav-MorRx/Sav-On Drugs, Nash Finch, Roundy’s/Mariano’s, Associated Food Stores, Leader, McKesson Health Mart, Good Neighbor, Astrup Drug, Winn Dixie, Big Y Foods, Harmons Grocery, Wal-Mart Canada, Safeway Canada, Loblaw’s, Le Groupe Jean Coutu, Shoppers Drug Mart, Rexall/Katz Group, Sobeys/Lawtons. PharmaSmart® also serves major worksites, military bases, university schools pharmacy, hospitals and medical clinics. PharmaSmart’s PS DataSmart® Health IT database currently holds more than 40 million targeted patient blood pressure readings. For more information visit the company's website at http://www.PharmaSmart.com.
About Chain Drug Review
Chain Drug Review is the only news publication serving the readership needs of the most powerful and engaged audiences in all of retail.